Substance Use Disorder Clinic Presentations
Below is a list of past Substance Use Disorder ECHO Clinic presentations. To view presentation slides, presenter bios, and additional resources, click view more.
Challenges in Addressing the Evolving Opioid Crisis During COVID-19 | September 3, 2020
Dr. Marwan Haddad and Daniel Bryant, LPC, from the Weitzman Institute, shares information on how they have met their SUD patient needs during the COVID-19 pandemic.
Presenter: Dr. Marwan Haddad and Daniel Bryant
Substance Use Disorder: Brains, Behavior & Diagnosis | August 6, 2020
Dr. Jonathan Robbins, an Assistant Professor of Medicine at Oregon Health & Science University, shares information to help interpret a “negative” benzodiazepine urine drug screen, discusses how to the determine next steps for further confirmatory testing and how to recognize the emergence of novel psychoactive substances, as well as the challenges of monitoring and reporting in a rapidly changing drug-use landscape.
Presenter: Dr. Jonathan Robbins
Methamphetamine Use Disorder | July 16, 2020
In this presentation, Dr. Jessica Gregg and Dr. Ximena Levander from Oregon Health & Science University discuss the history, chemical structure and epidemiology of methamphetamine use disorder. They also discuss treatment for methamphetamine use disorder, the current status of pharmacologic research, and the important of a harm reduction approach.
Presenters: Dr. Jessica Gregg, Dr. Ximena Levander
Managing Pain in Patients With Substance Use Disorder | June 4, 2020
Dr. Jonathan Robbins, Internal Medicine Physician at OHSU, shows how the neurobiology of pain mirrors the neurobiology of addiction and identifies ways to improve pain management in patients with substance use disorders.
Presenter: Dr. Jonathan Robbins
“Don’t You Mean Clonazepam?” A 40-Year-Old Woman with Opioid Use Disorder Requesting Detoxification from Clonazolam (Novel/Designer Benzodiazepine) | May 21, 2020
Dr. Ximena Levander, an Addiction Medicine & General Internal Medicine Fellow at Oregon Health & Science University, shares information to help interpret a “negative” benzodiazepine urine drug screen and determine next steps for further confirmatory testing and to recognize the emergence of novel psychoactive substances and the challenges of monitoring and reporting in a rapidly changing drug-use landscape.
Presenter: Dr. Ximena Levander
SUD Peers in COVID-19: Challenges, Resiliency & Emerging Strategies | May 7, 2020
Debra Buffaloboy, Peer Consultant for the Northwest Portland Area Indian Health Board, discusses the challenges of peer recovery for those with substance use disorder in the COVID-19 pandemic. She shares strategies for resiliency and providing services.
Presenter: Debra Buffaloboy
Buprenorphine Prescribing in a Pandemic | April 16, 2020
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews best practices for buprenorphine prescribing during COVID‐19 and the changing regulations around prescribing. She also shares a sample model for increasing access to buprenorphine.
Presenters: Dr. Jessica Gregg, Dr. Jennifer Hartley
Trauma Informed Care and COVID-19 | April 2, 2020
Dr. Danica Love Brown, Behavioral Health Manager at the Northwest Portland Area Indian Health Board, describes the principles of trauma informed care and shares some tips for mental health wellness during quarantine.
Presenter: Dr. Danica Love Brown
COVID-19 | March 18, 2020
Dr. Jorge Mera, Director of Infectious Diseases for the Cherokee Nation Health Service, and Whitney Essex, Family Nurse Practitioner for the Cherokee Nation Health Service, provide an overview of COVID-19, including the epidemiology, clinical manifestations, testing for COVID-19, and how to prepare your clinic for the pandemic.
Presenters: Dr. Jorge Mera, Whitney Essex
Microdose Buprenorphine Inductions | March 5, 2020
Dr. Jennifer Hartley, a Family Medicine Practitioner at Portland Urgent Care, defines microdosing, provides an overview of microdosing protocols for buprenorphine, reviews several case studies, and explains how to implement outpatient buprenorphine microdosing.
Presenter: Dr. Jennifer Hartley
Introduction to Harm Reduction | February 20, 2020
Jessica Rienstra, Hepatitis C Project Coordinator at Lummi Tribal Health Center, shares an overview of harm reduction principles and the benefits of harm reduction for both patients and providers. She also shares some history and provides an overview of the Lummi Primary Integrated Care Syringe Service Program, formerly the Needle Exchange Program.
Presenter: Jessica Rienstra
Trickster Tails | February 6, 2020
Dr. Danica Love Brown, Behavioral Health Manager at the Northwest Portland Area Indian Health Board, demonstrates how traditional indigenous knowledge and stories can aid in overcoming trauma related to opioid addiction.
Presenter: Dr. Danica Love Brown
Medications for Opioid Use Disorder: Who Should Get What When? | January 16, 2020
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares methadone, buprenorphine, and extended release naltrexone in terms of efficacy on a stable dose, induction, retention, and systems-level constraints.
Presenter: Dr. Jessica Gregg
Maternal Substance Use Disorders and Infant Withdrawal Syndromes in Hospital Deliveries Among American Indians/Alaska Natives | December 19, 2019
In this presentation, Dr. Chiao-Wen Lan, Dr. Tom Weiser, and Sujata Joshi from the Northwest Portland Area Indian Health Board, discuss how prenatal exposure to substances can negatively affect fetal development. They also look at the effects on fetal development as a result of fetal alcohol spectrum disorder and neonatal abstinence syndrome.
Presenters: Dr. Chiao-Wen Lan, Dr. Thomas Weiser, Sujata Joshi
Microdose Buprenorphine Inductions | December 5, 2019
Dr. Jennifer Hartley, a Family Medicine Practitioner at Portland Urgent Care, defines microdosing, provides an overview of microdosing protocols for buprenorphine, reviews several case studies, and explains how to implement outpatient buprenorphine microdosing.
Presenter: Dr. Jennifer Hartley
Let’s Talk About PrEP | November 21, 2019
Dr. Jorge Mera, Director of Infectious Diseases for Cherokee Nation Health Service, and Whitney Essex, Family Nurse Practitioner for Cherokee Nation Health Service, explain PrEP, the process in which an HIV-negative person who is at very high risk for acquiring HIV takes daily medication to reduce their risk. They provide strategies for assessing candidates for PrEP, and the process for starting new patients on PrEP.
Presenters: Dr. Jorge Mera, Whitney Essex
Complex Persistent Dependence, Withdrawal and Opioid Use Disorder | November 7, 2019
Dr. Jane Ballantyne, an Anesthesiologist at the University of Washington Medical Center, speaks about effective management of patients with persistent opioid dependence and addiction. Dr. Ballantyne shares challenges in and strategies for overcoming opioid dependence and managing withdrawal symptoms.
Presenter: Dr. Jane Ballantyne
Substance Data Sources for Program and Public Health Planning | October 17, 2019
Sujata Joshi and Heidi Lovejoy, epidemiologists at the Northwest Portland Area Indian Health Board, speak about SUD data collection efforts at tribal epidemiology centers across Indian Country. They provide sources of data for tribes at the local and national levels and share relevant data from Washington state and the Pacific Northwest.
Presenters: Sujata Joshi, Heidi Lovejoy
Creating Affirming Clinic Environments for Two Spirit and LGBTQ Patients | October 3, 2019
Morgan Thomas, Two Spirit and LGBTQ+ Outreach Coordinator at the Northwest Portland Area Indian Health Board, speaks about the importance of creating affirming clinic spaces for Two Spirit and LGBTQ+ patients, and describes four actionable elements that create affirming environments.
Presenter: Morgan Thomas
How to Start a Naloxone Program | September 19, 2019
Alison Newman, a Continuing Education Specialist at the Alcohol and Drug Abuse Institute at the University of Washington, gives an in-depth overview of the steps and training necessary to implement a naloxone program.
Presenter: Alison Newman
Methamphetamine Use Disorder | September 5, 2019
Dr. Ximena Levander and Dr. Jessica Gregg, from Oregon Health & Science University, discuss the scope of the methamphetamine epidemic, behavioral interventions, and present research on medications to treat methamphetamine use disorder.
Presenters: Dr. Ximena Levander, Dr. Jessica Gregg
Methadone: Opioid Replacement in the Treatment of Opioid Use Disorder | August 1, 2019
Dr. Gil Traylor, Medical Director of the Swinomish Indian Health Clinic, presents on the history, efficacy, risks, and benefits of using methadone as a treatment for opioid use disorder.
Presenter: Dr. Gil Traylor
Trauma Informed Care | July 20, 2019
Dr. Danica Love Brown, Behavioral Health Manager at the Northwest Portland Area Indian Health Board, defines trauma informed care and provides an overview of the basic principles of trauma informed care, as well as the types of trauma, and the impact of trauma on the brain.
Presenter: Dr. Danica Love Brown
Siletz Community Health Clinic: Implementing a Medication-Assisted Treatment (MAT) Program | June 6, 2019
Lisa Taylor, a family nurse practitioner at Siletz Community Health Clinic, shares the story of the Siletz Community Health Clinic in creating a medication-assisted treatment program to combat the opioid epidemic in their community. She also discusses practical implementation of the program and overcoming barriers to care.
Presenter: Lisa Taylor
Managing Pain in Patients with Substance Use Disorder | May 16, 2019
Dr. Jonathan Robbins, Internal Medicine Physician at OHSU, shows how the neurobiology of pain mirrors the neurobiology of addiction and identifies ways to improve pain management in patients with substance use disorders.
Presenter: Dr. Jonathan Robbins
Integrating Culture-Based Strategies to Address SUDs | May 2, 2019
Dr. Melissa Walls, Director of the Great Lakes Hub for the Johns Hopkins Center for American Indian Health, examines the role of culture as a health promoting factor in AI/AN communities. She also conceptualizes dimensions of Indigenous culture most important to health promotion in AI/AN communities.
Presenter: Dr. Melissa Walls
The Role of Behavioral Interventions in Substance Use Disorder Treatment | April 18, 2019
Dr. Danica Love Brown, Behavioral Health Manager at the Northwest Portland Area Indian Health Board, describes different types of behavioral therapies, including cognitive behavioral therapy, dialectical behavioral therapy, motivational enhancement therapy, and experiential therapies, and how they can assist in substance use disorder treatment.
Presenter: Dr. Danica Love Brown
Alcohol Use Disorder Pharmacotherapy | April 4, 2019
Dr. Zeina Saliba, Medical Director of George Washington University Hospital Psychiatric Services, discusses pharmalogic options for treating alcohol use disorder, their benefits, side-effects, and risks. Dr. Saliba also shares dosage guidance.
Presenter: Dr. Zeina Saliba
Introduction to Peer Recovery Mentors: A New Perspective in Non-Traditional Settings | March 21, 2019
O’Nesha Cochran, a certified peer recovery mentor, shares her story and provides an overview of peer recovery support, how people interested in peer recovery can become certified, and potential barriers to peer support.
Presenter: O’Nesha Cochran
The Language of Addiction | March 7, 2019
Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the language recommended by the Office of National Drug Control Policy.
Presenter: Dr. Karla Thornton
Opioid Treatment Failure | February 21, 2019
Dr. Jonathan Robbins, an internal medicine physician at Oregon Health & Science University, speaks about the the universal precautions used in opioid prescribing, what opioid success and failure look like in primary care, and how to use a risk-benefit ratio when deciding to prescribe opioids.
Presenter: Dr. Jonathan Robbins
Medications for OUD: Who Should Get What When? | February 7, 2019
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, compares buprenorphine, methadone, and extended release naltrexone in terms of efficacy, induction, retention, operational restraints, and other clinical variables when used for treating opioid use disorder.
Presenter: Dr. Jessica Gregg
Neurobiology and Diagnosis of SUDs | January 17, 2019
Dr. Jessica Gregg, Associate Professor of Medicine at Oregon Health and Science University, reviews the diagnostic criteria for substance use disorders and examines the different ways in which substance use disorders can develop.
Presenter: Dr. Jessica Gregg
To access any of the above presentations, please contact echo@npaihb.org